Our Research Goals
To work with people who have lived experience of mental illness (consumers and carers) to negotiate research priorities for now and in the future.
Understanding why antidepressants and other medications can work so well for some people, while having no effects on others.
To enhance brain research through the use of advancing innovative neuro-technologies and collaborating with research centres in Australia and the rest of the world.
To translate pharmacogenomics of antidepressants to personalised treatments for depression. We have had a substantial focus on pharmacogenomics of antidepressants and other medicines.
To pioneer research in brain disorders in the realms of psychiatry, such as attention deficit hyperactivity disorder, autism, eating disorders, depression, bipolar disorder, schizophrenia, anxiety, obsessive compulsive disorder, dementia, gambling, substance abuse, alcoholism, stroke, parkinsonism, epilepsy, and others neurological disorders.